Neurones Statistics

Total Valuation

Neurones has a market cap or net worth of EUR 1.10 billion. The enterprise value is 929.84 million.

Market Cap	1.10B
Enterprise Value	929.84M

Important Dates

The next estimated earnings date is Wednesday, March 5, 2025.

Earnings Date	Mar 5, 2025
Ex-Dividend Date	n/a

Share Statistics

Neurones has 24.27 million shares outstanding. The number of shares has increased by 0.11% in one year.

Current Share Class	n/a
Shares Outstanding	24.27M
Shares Change (YoY)	+0.11%
Shares Change (QoQ)	+0.16%
Owned by Insiders (%)	63.75%
Owned by Institutions (%)	15.96%
Float	8.80M

Valuation Ratios

The trailing PE ratio is 22.81 and the forward PE ratio is 21.86.

PE Ratio	22.81
Forward PE	21.86
PS Ratio	1.42
PB Ratio	3.15
P/TBV Ratio	n/a
P/FCF Ratio	25.68
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 10.30, with an EV/FCF ratio of 21.67.

EV / Earnings	19.18
EV / Sales	1.20
EV / EBITDA	10.30
EV / EBIT	12.64
EV / FCF	21.67

Financial Position

The company has a current ratio of 2.24, with a Debt / Equity ratio of 0.12.

Current Ratio	2.24
Quick Ratio	2.18
Debt / Equity	0.12
Debt / EBITDA	0.52
Debt / FCF	1.09
Interest Coverage	48.40

Financial Efficiency

Return on equity (ROE) is 14.87% and return on invested capital (ROIC) is 10.67%.

Return on Equity (ROE)	14.87%
Return on Assets (ROA)	7.06%
Return on Capital (ROIC)	10.67%
Revenue Per Employee	113,143
Profits Per Employee	7,080
Employee Count	6,749
Asset Turnover	1.19
Inventory Turnover	243.32

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +20.93% in the last 52 weeks. The beta is 0.58, so Neurones's price volatility has been lower than the market average.

Beta (5Y)	0.58
52-Week Price Change	+20.93%
50-Day Moving Average	44.95
200-Day Moving Average	44.55
Relative Strength Index (RSI)	48.83
Average Volume (20 Days)	15,185

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Neurones had revenue of EUR 774.91 million and earned 48.49 million in profits. Earnings per share was 1.99.

Revenue	774.91M
Gross Profit	366.50M
Operating Income	73.57M
Pretax Income	81.21M
Net Income	48.49M
EBITDA	82.20M
EBIT	73.57M
Earnings Per Share (EPS)	1.99

Full Income Statement

Balance Sheet

The company has 268.12 million in cash and 46.73 million in debt, giving a net cash position of 221.39 million or 9.12 per share.

Cash & Cash Equivalents	268.12M
Total Debt	46.73M
Net Cash	221.39M
Net Cash Per Share	9.12
Equity (Book Value)	398.95M
Book Value Per Share	14.41
Working Capital	302.94M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 62.18 million and capital expenditures -19.27 million, giving a free cash flow of 42.92 million.

Operating Cash Flow	62.18M
Capital Expenditures	-19.27M
Free Cash Flow	42.92M
FCF Per Share	1.77

Full Cash Flow Statement

Margins

Gross margin is 47.30%, with operating and profit margins of 9.49% and 6.26%.

Gross Margin	47.30%
Operating Margin	9.49%
Pretax Margin	10.48%
Profit Margin	6.26%
EBITDA Margin	10.61%
EBIT Margin	9.49%
FCF Margin	5.54%

Dividends & Yields

This stock pays an annual dividend of 1.20, which amounts to a dividend yield of 2.67%.

Dividend Per Share	1.20
Dividend Yield	2.67%
Dividend Growth (YoY)	9.09%
Years of Dividend Growth	1
Payout Ratio	60.07%
Buyback Yield	-0.11%
Shareholder Yield	2.56%
Earnings Yield	4.38%
FCF Yield	3.89%

Dividend Details

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Neurones has an Altman Z-Score of 4.23.

Altman Z-Score	4.23
Piotroski F-Score	n/a